Skip To Main Content
William Petri on Muck Rack

William Petri

As seen in: MSN, BBC Mundo, Business Insider, Nature, Yahoo News, ABC News (Australia), Diario ABC, PBS News Hour - Health, PBS NewsHour, El Español and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with William

Contact William, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Shigellosis

|
By Jennifer E. Hendrick, William Petri
| The Lancet Verified
FREE with registration! Log in or register to access the full article. References 1. Vos, T ∙ Lim, SS ∙ Abbafati, C ∙ et al., the GBD 2019 Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet. 2020; 396:1204-1222 2. Liu, J ∙ Platts-Mills, JA ∙ Juma, J ∙ et al.
Open in Who Shared Issue with article?

Shigellosis

|
By Jennifer E. Hendrick, William Petri
| The Lancet Verified
FREE with registration! Log in or register to access the full article. References 1. Vos, T ∙ Lim, SS ∙ Abbafati, C ∙ et al., the GBD 2019 Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet. 2020; 396:1204-1222 2. Liu, J ∙ Platts-Mills, JA ∙ Juma, J ∙ et al.
Open in Who Shared Issue with article?

Anti-interleukin-23 treatment linked to improved Clostridioides difficile infection survival

|
By Robert Preissner, William Petri, Saskia Preissner, Gregory R. Madden
| Taylor & Francis Online
ABSTRACT Clostridioides difficile is a leading cause of healthcare-associated infection, and an unacceptably high proportion of patients with C. difficile infection die despite conventional antibiotic treatment. Host-directed immunotherapy has been proposed as an ideal treatment modality for C. difficile infection to mitigate the underlying toxin-mediated pathogenic immune response while sparing protective gut microbes.
Open in Who Shared Issue with article?
See all 1,039 licensed articles (1,055 Total)